PAPACCIO, Federica
 Distribuzione geografica
Continente #
NA - Nord America 503
EU - Europa 315
AS - Asia 219
SA - Sud America 60
OC - Oceania 4
AF - Africa 1
Totale 1.102
Nazione #
US - Stati Uniti d'America 500
SG - Singapore 143
RU - Federazione Russa 126
IT - Italia 81
BR - Brasile 56
CN - Cina 32
IE - Irlanda 27
DE - Germania 23
HK - Hong Kong 21
NL - Olanda 17
UA - Ucraina 8
GB - Regno Unito 7
AT - Austria 6
BD - Bangladesh 4
BE - Belgio 4
ES - Italia 4
IN - India 4
TR - Turchia 4
AU - Australia 3
FI - Finlandia 3
FR - Francia 3
UZ - Uzbekistan 3
HU - Ungheria 2
JP - Giappone 2
AR - Argentina 1
CA - Canada 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 1.102
Città #
Chandler 128
Princeton 95
Singapore 64
Moscow 53
Ashburn 36
Dublin 27
Andover 24
Redwood City 23
Hong Kong 21
Dallas 18
Wilmington 18
Ann Arbor 15
Naples 13
Amsterdam 11
Nuremberg 9
Seattle 8
Sarno 6
Washington 5
Milan 4
Springfield 4
Vienna 4
Aprilia 3
Beijing 3
Duncan 3
Edinburgh 3
Hangzhou 3
Houston 3
Munich 3
Norwalk 3
Paris 3
Rome 3
Tashkent 3
Assago 2
Bourne End 2
Budapest 2
Campinas 2
Campo Grande 2
Castellammare di Stabia 2
Cuiabá 2
Dhaka 2
Ferrara 2
Guarulhos 2
Islington 2
Istanbul 2
Jacksonville 2
Lappeenranta 2
Madrid 2
New Delhi 2
Poggiomarino 2
Pune 2
São Paulo 2
Tokyo 2
Weifang 2
Yubileyny 2
Amman 1
Amparo do Serra 1
América 1
Anápolis 1
Areia Branca 1
Artur Nogueira 1
Atibaia 1
Aydin 1
Bacabal 1
Bady Bassitt 1
Balıkesir 1
Baoding 1
Barbacena 1
Barishal 1
Belo Horizonte 1
Belvedere Spinello 1
Boardman 1
Bogotá 1
Boston 1
Brejões 1
Brighton 1
Brussels 1
Böblingen 1
Camaçari 1
Cambé 1
Candeias 1
Caruaru 1
Caserta 1
Catende 1
Chernivtsi 1
Chicago 1
Cosmópolis 1
Cravinhos 1
Curitiba 1
Daan 1
Dambulla 1
Duque de Caxias 1
Erechim 1
Esslingen am Neckar 1
Fairfield 1
Fisciano 1
Forest City 1
Fort Worth 1
Goiânia 1
Gravataí 1
Guangzhou 1
Totale 709
Nome #
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer 54
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress 51
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 45
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy 41
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" 38
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo 38
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 38
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development 37
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study 36
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 33
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo 33
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 33
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 32
In the literature: August 2018 32
Implication of the Hedgehog pathway in hepatocellular carcinoma 31
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer 31
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization 30
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 28
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial 28
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer 28
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells 28
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 27
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 26
How organoids can improve personalized treatment in patients with gastro-esophageal tumors 24
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 22
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 20
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 19
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 19
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision 18
Circulating cancer stem cells: an interesting niche to explore 17
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 16
Adipose Stem Cells and Their Interplay with Cancer Cells and Mitochondrial Reservoir: A New Promising Target 16
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 15
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 15
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 15
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 14
Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy 14
Will Organoids Fill the Gap towards Functional Precision Medicine? 14
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. 13
Stemness markers of osteosarcoma 12
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 11
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 11
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 11
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 11
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 10
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 10
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 10
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine 10
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 8
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models 8
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 8
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 8
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 8
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 7
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 6
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 6
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 6
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 6
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 5
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 4
New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma 4
Synergistic effect of vismodegib and cisplatin in NSCLC models via autophagy 4
Patient-derived organoids as a tool for modelling localized colorectal cancer 4
Totale 1.257
Categoria #
all - tutte 8.209
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.209


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 25 30 13 4 1 5 3 9 3
2021/2022127 3 0 2 0 1 0 0 10 26 0 16 69
2022/2023370 26 0 6 42 46 72 6 52 83 2 30 5
2023/2024202 7 14 10 4 10 34 4 8 28 2 9 72
2024/2025465 8 24 37 17 27 76 107 34 95 40 0 0
Totale 1.257